ClinicalTrials.Veeva

Menu

Improved HRV, Inflammation Markers and Endothelial Function After TAVI (bTAVI)

U

University Medical Centre Ljubljana

Status

Completed

Conditions

Severe Aortic Stenosis
TAVI

Treatments

Diagnostic Test: Blood withdrawal
Diagnostic Test: Flow mediated vasodilatation
Diagnostic Test: High resolution ECG

Study type

Observational

Funder types

Other

Identifiers

NCT04286893
UKCLbTAVI

Details and patient eligibility

About

Severe aortic valve stenosis is known to affect heart haemodynamics, endothelial function and body inflammation markers. Our aim is to investigate the weather transcatheter aortic valve implantation in patients with severe aortic stenosis affects heart rate variability, inflammation markers and endothelial function.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • TAVI

Exclusion criteria

  • stage V chronic kidney disease
  • active malignancies

Trial design

50 participants in 1 patient group

TAVI group
Description:
Consecutive patients undergoing TAVI
Treatment:
Diagnostic Test: Blood withdrawal
Diagnostic Test: High resolution ECG
Diagnostic Test: Flow mediated vasodilatation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems